New Challenges for Hypertension Treatment

被引:8
作者
Rosas-Peralta, Martin [1 ]
Marcela Jimenez-Genchi, Gladys [2 ]
机构
[1] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Programa A Todo Corazon Codigo Infarto, Jefe Area Med, Mexico City, DF, Mexico
[2] Inst Mexicano Seguro Social, Ctr Med Nacl Siglo 21, Programa A Todo Corazon, Mexico City, DF, Mexico
关键词
Hypertension; Guidelines; Therapy; Mexico; ASSOCIATION TASK-FORCE; CLINICAL-PRACTICE GUIDELINES; SYSTOLIC BLOOD-PRESSURE; AMERICAN-COLLEGE; CARDIOVASCULAR RISK; GLOBAL BURDEN; TRIAL; METAANALYSIS; PREVENTION; MANAGEMENT;
D O I
10.1016/j.arcmed.2018.11.005
中图分类号
R-3 [医学研究方法]; R3 [基础医学];
学科分类号
1001 ;
摘要
In Mexico around 22.3 million adult Mexicans have hypertension. An estimated 65 million adult Americans, or nearly one in four of the adult population of the United States, have hypertension. However, with the new classification from 2017 ACC/AHA guidelines which considered >= 130/80 mmHg as the new cutoff point to diagnosis of hypertension, the number of patients is at least twice, in other words around 40 million adult Mexicans potentially have hypertension. Although this new classification is directed to be more efficient in the changes of life style and nondrug strategies to stage one hypertension the real word evidence suggest that we need to be more careful in the selection of patients to be introduced in a drug therapy strategy. Elevations in systemic arterial pressures have been associated with increased cardiovascular morbidity and mortality including cardiovascular death, myocardial infarction, heart failure and stroke. It remains one of the most reversible causes of various disease states. This article aims to review current blood pressure (BP) targets and medical therapies for hypertension in the modern era, recognizing varying clinical characteristics such as comorbidities and patient risk profile. (C) 2018 IMSS. Published by Elsevier Inc. All rights reserved.
引用
收藏
页码:548 / 557
页数:10
相关论文
共 50 条
  • [31] Azilsartana Medoxomil: a New Possibilities in the Treatment of Hypertension. Pharmacological Properties
    Kobalava, Z. D.
    Villevalde, S. V.
    [J]. KARDIOLOGIYA, 2014, 54 (12) : 57 - 62
  • [32] Hypertension in children: new trends and challenges
    Feber, Janusz
    Ahmed, Maheen
    [J]. CLINICAL SCIENCE, 2010, 119 (3-4) : 151 - 161
  • [33] The pharmacology of hypertension-new challenges
    Mulvany, Michael J.
    [J]. ACTA PHARMACOLOGICA SINICA, 2006, 27 : 1 - 1
  • [34] Arterial Hypertension register in private clinics in Venezuela: RHAVEN Study
    Amaro-Alcala, J. J.
    Rosas-Aviles, R.
    Marval-Ortiz, J. J.
    Diaz-Espinoza, L.
    Gomez-Mancebo, J. R.
    Rodriguez-Urbaneja, F.
    Torres-Viera, J. M.
    Lopez-Nouel, R.
    Lopez-Gomez, L. E.
    Alaeddine-Noueihed, W.
    Martinez-Gutierrez, E.
    Duran-Castillo, M.
    Acosta-Martinez, J.
    [J]. HIPERTENSION Y RIESGO VASCULAR, 2019, 36 (02): : 85 - 95
  • [35] Trends in hypertension prevalence, awareness, treatment and control rates among Chinese adults, 1991-2015
    Ma, Shujing
    Yang, Liu
    Zhao, Min
    Magnussen, Costan G.
    Xi, Bo
    [J]. JOURNAL OF HYPERTENSION, 2021, 39 (04) : 740 - 748
  • [37] Challenges of managing hypertension in Pakistan-a review
    Elahi, Adil
    Ali, Arzina Aziz
    Khan, Aamir Hameed
    Samad, Zainab
    Shahab, Hunaina
    Aziz, Namra
    Almas, Aysha
    [J]. CLINICAL HYPERTENSION, 2023, 29 (01)
  • [38] Treatment of Hypertension in Patients with Diabetes Mellitus: a Contemporary Approach
    Alencherry, Ben
    Laffin, Luke J.
    [J]. CURRENT CARDIOLOGY REPORTS, 2021, 23 (03)
  • [39] Update of the clinical guideline for hypertension diagnosis and treatment in Iran
    Bagherikholenjani, Fahimeh
    Shahidi, Shahla
    Khosravi, Alireza
    Mansouri, Asieh
    Ashoorion, Vahid
    Sarrafzadegan, Nizal
    [J]. CLINICAL HYPERTENSION, 2024, 30 (01)
  • [40] Rationale of treatment recommendations in the 2023 ESH hypertension guidelines
    Mancia, Giuseppe
    Brunstrom, Mattias
    Burnier, Michel
    Grassi, Guido
    Januszewicz, Andrzej
    Muiesan, Maria Lorenza
    Tsioufis, Konstantinos
    Kjeldsen, Sverre E.
    Kreutz, Reinhold
    [J]. EUROPEAN JOURNAL OF INTERNAL MEDICINE, 2024, 121 : 4 - 8